Related Experiment Video
Updated: Jul 13, 2025

13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
9.4K
miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives
Margarita Dobrzycka1, Anetta Sulewska2, Przemyslaw Biecek3
1Department of Ophthalmology, Medical University of Bialystok, 15-276 Bialystok, Poland.
International Journal of Molecular Sciences
|October 14, 2023
Summary
MicroRNAs (miRNAs) show promise as biomarkers and therapeutic targets for glaucoma, a leading cause of blindness. Research highlights their role in disease mechanisms but faces challenges in validation and accessibility.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Glaucoma is a complex neurodegenerative disease causing irreversible blindness.
- MicroRNAs (miRNAs) are key gene regulators implicated in glaucoma pathogenesis.
- Current understanding of miRNA roles in glaucoma requires further investigation.
Purpose of the Study:
- To review the advantages and disadvantages of miRNA studies in glaucoma.
- To discuss the potential of miRNAs as biomarkers for early detection and diagnosis.
- To explore miRNA utility in personalized medicine, therapy, and monitoring.
Main Methods:
- Literature review of miRNA-focused molecular studies in glaucoma.
- Discussion of miRNA potential in disease mechanisms and therapeutic applications.
- Analysis of limitations including data variability and tissue accessibility.
Main Results:
- miRNAs offer insights into glaucoma's molecular pathways and mechanisms.
- Potential for miRNAs as diagnostic biomarkers and therapeutic targets is significant.
- Challenges include study variability, small sample sizes, and limited ocular tissue access.
Conclusions:
- miRNA research provides valuable insights into glaucoma molecular mechanisms.
- Addressing limitations like variability and accessibility is crucial for clinical translation.
- Further validation and bioinformatics integration are needed to harness miRNA potential in glaucoma management.
Related Concept Videos
Glaucoma: Overview
600
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
600
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Open Angle Glaucoma: Treatment
471
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
471

